Northern Trust Corp Neuronetics, Inc. Transaction History

Northern Trust Corp

$572 Billion
Q1 2024

A detailed history of Northern Trust Corp transactions in Neuronetics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 56,860 shares of STIM stock, worth $99,505. This represents 0.0% of its overall portfolio holdings.

Number of Shares

56,860

Previous 49,099 15.81%

Holding current value

$99,505

Previous $142,000 90.14%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$2.68 - $4.8 $20,799 - $37,252	7,761 Added 15.81%	56,860 $270,000
Q3 2023 Nov 13, 2023	SELL	$1.29 - $2.22 $1,523 - $2,621	-1,181 Reduced 2.35%	49,099 $66,000
Q2 2023 Aug 11, 2023	SELL	$2.07 - $2.92 $11,186 - $15,779	-5,404 Reduced 9.7%	50,280 $108,000
Q1 2023 May 15, 2023	BUY	$2.81 - $6.71 $1,382 - $3,301	492 Added 0.89%	55,684 $162,000
Q4 2022 Feb 13, 2023	BUY	$3.44 - $6.87 $42,071 - $84,020	12,230 Added 28.47%	55,192 $379,000

Q3 2022 Nov 14, 2022	SELL	$2.35 - $4.66 $1,952 - $3,872	-831 Reduced 1.9%	42,962 $137,000
Q2 2022 Aug 12, 2022	SELL	$2.09 - $3.71 $372,684 - $661,559	-178,318 Reduced 80.28%	43,793 $141,000
Q1 2022 May 13, 2022	SELL	$2.84 - $4.52 $30,669 - $48,811	-10,799 Reduced 4.64%	222,111 $673,000
Q4 2021 Feb 08, 2022	SELL	$3.87 - $6.59 $49,137 - $83,673	-12,697 Reduced 5.17%	232,910 $1.04 Million
Q3 2021 Nov 15, 2021	BUY	$6.22 - $15.54 $47,564 - $118,834	7,647 Added 3.21%	245,607 $1.61 Million
Q2 2021 Aug 13, 2021	BUY	$10.15 - $17.25 $1.99 Million - $3.39 Million	196,380 Added 472.29%	237,960 $3.81 Million
Q1 2021 May 12, 2021	BUY	$10.6 - $21.27 $150,096 - $301,183	14,160 Added 51.64%	41,580 $515,000
Q4 2020 Feb 11, 2021	SELL	$4.95 - $11.45 $7,825 - $18,102	-1,581 Reduced 5.45%	27,420 $305,000
Q3 2020 Nov 16, 2020	BUY	$1.82 - $5.87 $3,903 - $12,591	2,145 Added 7.99%	29,001 $141,000
Q2 2020 Aug 14, 2020	SELL	$1.41 - $2.61 $195,435 - $361,764	-138,607 Reduced 83.77%	26,856 $52,000
Q1 2020 May 14, 2020	BUY	$1.28 - $4.5 $32,276 - $113,472	25,216 Added 17.98%	165,463 $312,000
Q4 2019 Feb 14, 2020	SELL	$4.03 - $9.22 $187,060 - $427,964	-46,417 Reduced 24.87%	140,247 $629,000
Q3 2019 Nov 13, 2019	BUY	$8.31 - $13.03 $440,812 - $691,189	53,046 Added 39.7%	186,664 $1.55 Million
Q2 2019 Aug 13, 2019	BUY	$9.0 - $17.2 $52,893 - $101,084	5,877 Added 4.6%	133,618 $1.67 Million
Q1 2019 May 13, 2019	BUY	$13.6 - $19.58 $755,384 - $1.09 Million	55,543 Added 76.93%	127,741 $1.95 Million
Q4 2018 Feb 12, 2019	SELL	$16.0 - $31.84 $120,944 - $240,678	-7,559 Reduced 9.48%	72,198 $1.4 Million
Q3 2018 Nov 14, 2018	BUY	$24.32 - $37.54 $1.69 Million - $2.61 Million	69,626 Added 687.26%	79,757 $2.56 Million
Q2 2018 Sep 18, 2018	BUY	$26.61 - $27.78 $269,585 - $281,439	10,131 New	10,131 $270,000

Others Institutions Holding STIM

# of Institutions

Shares Held

18.4M

Call Options Held

200

Put Options Held

3.6K

View Full List

About Neuronetics, Inc.

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $47.3M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

More about STIM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Neuronetics, Inc. Transaction History